gut microbiota

Gut bacteria may help predict lung cancer treatment success

Changes in gut bacteria, especially Akkermansia, could predict treatment success in people with lung cancer.

Bacteriophages and Lactic acid bacteria: a hidden challenge for dairy and probiotic production and how to control it

Douwe Van Sinderen, professor of Molecular Microbiology at School of Microbiology & APC Microbiome Ireland, focuses on bacteriophages infecting lactic acid bacteria used in food and probiotic applications.

Indigenous partnership reveals unique gut microbes and ethical research model

Ethical, long-term partnerships can uncover valuable scientific insights while respecting Indigenous knowledge.

Microbiota-derived molecule regulates immune cell metabolism and gut inflammation

Controlling cadaverine levels and the gut bacteria that produce it could help regulate immune cell metabolism and inflammation.

Gut microbiome–immune system crosstalk: from homeostasis to strain-level opportunities

Three infant-derived strains isolated and developed by Coree srl that are potentially interesting for immune support.

Enteric pathogens as active drivers of dysbiosis: lessons from Bacillus cereus and experimental models of the gut microbiota

Emilia Ghelardi, Professor of Microbiology and Molecular Microbiology at the University of Pisa, explains how pathogens can actively disrupt the integrity of the commensal community.

Gut microbiota linked to healthy longevity in the world’s oldest woman 

The abundance of Bifidobacterium may explain M116’s excellent cholesterol profile and low inflammation levels.

Reinforcing the gut barrier: how probiotics support intestinal integrity and immune health

Arthur Ouwehand, Technical Fellow at IFF Finland, discusses the components and vulnerabilities of the gut barrier and reviews how probiotics and related dietary interventions can support its structure and function.

Ketogenic diet and gut bacteria help slow brain tumor growth in mice

Targeting gut bacteria or butyrate could be a promising therapy for glioma.

Bifidobacterium longum subsp. infantis M-63: shaping early-life gut microbiota and immunity in healthy full-term infants

Akari Hiraku, researcher at Innovative Research Institute, Morinaga Milk Industry Co., presented clinical data on Bifidobacterium longum subsp. infantis M-63, a probiotic strain with a remarkable capacity to utilize HMOs.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top